XML 34 R23.htm IDEA: XBRL DOCUMENT v3.20.2
Summary of Significant Accounting Policies (Narrative) (Details)
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2020
USD ($)
Mar. 31, 2020
USD ($)
Dec. 31, 2019
USD ($)
item
Jun. 30, 2019
Jun. 30, 2020
USD ($)
Mar. 31, 2020
USD ($)
Jun. 30, 2019
Dec. 31, 2019
USD ($)
item
Feb. 29, 2020
USD ($)
Summary Of Significant Accounting Policies [Line Items]                  
Fair value of the financing derivative     $ 0         $ 0  
Financing derivative         $ 0
Continuation Advances   $ 34,000,000.0 $ 18,000,000.0   34,000,000 $ 52,000,000.0      
Deferred gain from Reverse Termination Fee 98,000,000       $ 98,000,000        
Period in which company must repay continuation advances if change-of-control transaction is entered into with third party         2 years        
Equity or debt financing that must be raised in a single transaction         $ 100,000,000        
Period in which company must raise equity or debt financing in a single transaction         2 years        
Contingent repayment liability $ 0 0     $ 0 $ 0      
Gain from Continuation Advances   $ 34,000,000.0     34,000,000     $ 18,000,000.0  
Fair value assets/liabilities transfer between levels         $ 0        
Measurement Input, Discount Rate [Member]                  
Summary Of Significant Accounting Policies [Line Items]                  
Derivative liability, measurement input | item     0.065         0.065  
Sales Revenue, Net [Member] | TOMY Digital Biology Co. [Member]                  
Summary Of Significant Accounting Policies [Line Items]                  
Concentration risk, percentage 15.00%     23.00% 11.00%   20.00%